{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,3,29]],"date-time":"2025-03-29T00:10:12Z","timestamp":1743207012115,"version":"3.40.3"},"reference-count":13,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,3,28]]},"DOI":"10.7759\/cureus.81382","type":"journal-article","created":{"date-parts":[[2025,3,28]],"date-time":"2025-03-28T23:54:53Z","timestamp":1743206093000},"source":"Crossref","is-referenced-by-count":0,"title":["Outcomes of Combined Therapy With Focal Laser and Intravitreal Bevacizumab for Retinal Arterial Macroaneurysm: A Case Series"],"prefix":"10.7759","author":[{"given":"Alex","family":"Jemelian","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Moises","family":"Enghelberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000019077","article-title":"To treat or not to treat: a clinical series of retinal arterial macroaneurysms: a single-center retrospective study","volume":"99","author":"Cho WH","year":"2020","unstructured":"Cho WH, Chiang WY, Chen CH, Kuo HK. To treat or not to treat: a clinical series of retinal arterial macroaneurysms: a single-center retrospective study. Medicine (Baltimore). 2020, 99:e19077. 10.1097\/MD.0000000000019077","journal-title":"Medicine (Baltimore)"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1159\/000334788","article-title":"Long-term follow-up of intravitreal bevacizumab in retinal arterial macroaneurysm: a case report","volume":"2","author":"Golan S","year":"2011","unstructured":"Golan S, Goldenberg D, Goldstein M. Long-term follow-up of intravitreal bevacizumab in retinal arterial macroaneurysm: a case report. Case Rep Ophthalmol. 2011, 2:387-91. 10.1159\/000334788","journal-title":"Case Rep Ophthalmol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.3928\/15428877-20100830-07","article-title":"Management of ruptured retinal arterial macroaneurysm with intravitreal bevacizumab","volume":"41","author":"Javey G","year":"2010","unstructured":"Javey G, Moshfeghi AN, Moshfeghi AA. Management of ruptured retinal arterial macroaneurysm with intravitreal bevacizumab. Ophthalmic Surg Lasers Imaging. 2010, 41:e1-5. 10.3928\/15428877-20100830-07","journal-title":"Ophthalmic Surg Lasers Imaging"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1136\/bjo.71.11.817","article-title":"Retinal arterial macroaneurysms: a retrospective study of 40 patients","volume":"71","author":"Lavin MJ","year":"1987","unstructured":"Lavin MJ, Marsh RJ, Peart S, Rehman A. Retinal arterial macroaneurysms: a retrospective study of 40 patients. Br J Ophthalmol. 1987, 71:817-25. 10.1136\/bjo.71.11.817","journal-title":"Br J Ophthalmol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1038\/sj.eye.6702068","article-title":"Retinal artery macroaneurysms: clinical and fluorescein angiographic features in 34 patients","volume":"20","author":"Moosavi RA","year":"2006","unstructured":"Moosavi RA, Fong KC, Chopdar A. Retinal artery macroaneurysms: clinical and fluorescein angiographic features in 34 patients. Eye (Lond). 2006, 20:1011-20. 10.1038\/sj.eye.6702068","journal-title":"Eye (Lond)"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1136\/bjo.74.10.595","article-title":"Retinal arterial macroaneurysms: risk factors and natural history","volume":"74","author":"Panton RW","year":"1990","unstructured":"Panton RW, Goldberg MF, Farber MD. Retinal arterial macroaneurysms: risk factors and natural history. Br J Ophthalmol. 1990, 74:595-600. 10.1136\/bjo.74.10.595","journal-title":"Br J Ophthalmol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.22608\/APO.201766","article-title":"Laser and anti-vascular endothelial growth factor agent treatments for retinal arterial macroaneurysm","volume":"6","author":"Chen YY","year":"2017","unstructured":"Chen YY, Lin LY, Chang PY, Chen FT, Mai EL, Wang JK. Laser and anti-vascular endothelial growth factor agent treatments for retinal arterial macroaneurysm. Asia Pac J Ophthalmol (Phila). 2017, 6:444-9. 10.22608\/APO.201766","journal-title":"Asia Pac J Ophthalmol (Phila)"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajo.2012.12.003","article-title":"Intravitreal bevacizumab for symptomatic retinal arterial macroaneurysm","volume":"155","author":"Cho HJ","year":"2013","unstructured":"Cho HJ, Rhee TK, Kim HS, Han JI, Lee DW, Cho SW, Kim JW. Intravitreal bevacizumab for symptomatic retinal arterial macroaneurysm. Am J Ophthalmol. 2013, 155:898-904. 10.1016\/j.ajo.2012.12.003","journal-title":"Am J Ophthalmol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1177\/2515841420988210","article-title":"Alone laser versus bevacizumab plus laser for diffuse diabetic macular edema (ALBA randomized trial)","volume":"13","author":"Pareja-R\u00edos A","year":"2021","unstructured":"Pareja-R\u00edos A, de Armas-Ramos E, Aldea-Perona A, Bonaque-Gonz\u00e1lez S. Alone laser versus bevacizumab plus laser for diffuse diabetic macular edema (ALBA randomized trial). Ther Adv Ophthalmol. 2021, 13:2515841420988210. 10.1177\/2515841420988210","journal-title":"Ther Adv Ophthalmol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.2147\/OPTH.S23535","article-title":"The use of bevacizumab in a multilevel retinal hemorrhage secondary to retinal macroaneurysm: a 39-month follow-up case report","volume":"5","author":"Tsakpinis D","year":"2011","unstructured":"Tsakpinis D, Nasr MB, Tranos P, et al.. The use of bevacizumab in a multilevel retinal hemorrhage secondary to retinal macroaneurysm: a 39-month follow-up case report. Clin Ophthalmol. 2011, 5:1475-7. 10.2147\/OPTH.S23535","journal-title":"Clin Ophthalmol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2010.03.045","article-title":"A prospective randomized trial of intravitreal bevacizumab or laser therapy in the management of diabetic macular edema (BOLT study) 12-month data: report 2","volume":"117","author":"Michaelides M","year":"2010","unstructured":"Michaelides M, Kaines A, Hamilton RD, et al.. A prospective randomized trial of intravitreal bevacizumab or laser therapy in the management of diabetic macular edema (BOLT study) 12-month data: report 2. Ophthalmology. 2010, 117:1078-86.e2. 10.1016\/j.ophtha.2010.03.045","journal-title":"Ophthalmology"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1001\/archophthalmol.2012.393","article-title":"A 2-year prospective randomized controlled trial of intravitreal bevacizumab or laser therapy (BOLT) in the management of diabetic macular edema: 24-month data: report 3","volume":"130","author":"Rajendram R","year":"2012","unstructured":"Rajendram R, Fraser-Bell S, Kaines A, et al.. A 2-year prospective randomized controlled trial of intravitreal bevacizumab or laser therapy (BOLT) in the management of diabetic macular edema: 24-month data: report 3. Arch Ophthalmol. 2012, 130:972-9. 10.1001\/archophthalmol.2012.393","journal-title":"Arch Ophthalmol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1016\/j.optom.2013.08.002","article-title":"Ruptured retinal arterial macroaneurysm: diagnosis and management","volume":"7","author":"Speilburg AM","year":"2014","unstructured":"Speilburg AM, Klemencic SA. Ruptured retinal arterial macroaneurysm: diagnosis and management. J Optom. 2014, 7:131-7. 10.1016\/j.optom.2013.08.002","journal-title":"J Optom"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/321571-outcomes-of-combined-therapy-with-focal-laser-and-intravitreal-bevacizumab-for-retinal-arterial-macroaneurysm-a-case-series","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,28]],"date-time":"2025-03-28T23:54:55Z","timestamp":1743206095000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/321571-outcomes-of-combined-therapy-with-focal-laser-and-intravitreal-bevacizumab-for-retinal-arterial-macroaneurysm-a-case-series"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,28]]},"references-count":13,"URL":"https:\/\/doi.org\/10.7759\/cureus.81382","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,3,28]]}}}